Sanofi Companies

 
Stock Quotes for Sanofi Companies top ^
  • Industry: Drug Manufacturers - Specialty & Generic
  • Sector: Healthcare
  • Stock Style: Large Value
  • Morningstar Rating: 4 Stars
Sign-up for sny investment picks
  • Industry: Drug Manufacturers - Specialty & Generic
  • Sector: Healthcare
  • Stock Style: Large Value
  • Morningstar Rating: 4 Stars
Sign-up for san investment picks
  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
  • Stock Style: Mid Growth
Sign-up for 500674 investment picks
  • Industry: Drug Manufacturers - Specialty & Generic
  • Sector: Healthcare
  • Stock Style: Large Value
  • Morningstar Rating: 4 Stars
Sign-up for sny investment picks

 
News Articles for Sanofi Companies top ^
2014/12/2
Parties have entered into exclusive negotiations and expect to sign the transaction in H1 2015 Goal to improve innovation effectiveness in drug discovery and pre-clinical development Building pipeline focused on oncology I nnovation bridge from academia to Pharma Long-term outsourcing collaboration on key drug discovery services for Sanofi; Evotec will acquire Sanofi's scientific operations in Toulouse Creation of Evotec's European compound management facility and service Pioneering open innovation programme with Sanofi and Evotec offering their combined approx.
Sign-up for Evotec and Sanofi Enter Into Exclusive Negotiations for a Major Multi-Component Strategic Collaboration investment picks
2014/11/18
- Former Director of the NIH Vaccine Research Center to Spearhead Sanofi Efforts, and Contribution to Global Fight against Ebola - PARIS , Nov.
Sign-up for Sanofi Names Chief Scientific Officer Gary Nabel as Sanofi Ebola Response Coordinator investment picks
The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been brought on behalf of those who purchased or otherwise acquired the securities of Sanofi (“Sanofi” or the “Company”) (NYSE: SNY) between February 7, 2013 and December 3, 2014, inclusive (the “Class Period”). If you purchased or otherwise acquired Sanofi securities during the Class Period, you may move the Court for appointment as lead plaintiff by no later than February 2, 2015.
Sign-up for Lieff Cabraser Announces Class Action Litigation Against Sanofi – SNY investment picks
Sanofi Commitment to Research and Develop TB Treatments, Diagnostics and Vaccines Spans More than 50 Years BRIDGEWATER, N.J. , Dec.
Sign-up for Sanofi Receives FDA Approval of Priftin® (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection investment picks
The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the February 2, 2015 deadline to move for appointment as lead plaintiff in the securities class action litigation brought on behalf of investors who purchased or otherwise acquired the securities of Sanofi (or the “Company”) (NYSE:SNY) between February 7, 2013 and December 3, 2014, inclusive (the “Class Period”). If you purchased or otherwise acquired Sanofi securities during the Class Period, you may move the Court for appointment as lead plaintiff by no later than February 2, 2015.
Sign-up for Lieff Cabraser Reminds Sanofi Investors of Upcoming Deadline in Class Action Litigation - SNY investment picks
- Includes New Data Showing Fluzone High-Dose Vaccine More Efficacious Than Standard-Dose Fluzone Vaccine - SWIFTWATER, Pa.
Sign-up for Sanofi Pasteur Announces FDA Approval of Updated Prescribing Information for Fluzone® High-Dose Vaccine for Adults 65 and Older investment picks
- The first and only four-strain influenza vaccine option administered intradermally - - Helps protect adults 18 through 64 years of age against an additional influenza B strain - SWIFTWATER, Pa.
Sign-up for Sanofi Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent (Influenza Vaccine) for Adults investment picks
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Sanofi (“Sanofi” or the “Company”) (NYSE: SNY) securities during the period between February 7, 2013 and December 3, 2014, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until February 2, 2015 to seek appointment as lead plaintiff.
Sign-up for SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Sanofi To Contact Brower Piven Before The February 2, 2015 Lead Plaintiff Deadline In Class Action Lawsuit investment picks
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Sanofi (“Sanofi” or the “Company”) (NYSE: SNY) securities during the period between February 7, 2013 and December 3, 2014, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until February 2, 2015 to seek appointment as lead plaintiff.
Sign-up for SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Sanofi To Contact Brower Piven Before The February 2, 2015 Lead Plaintiff Deadline In Class Action Lawsuit investment picks
PARIS , Oct.
Sign-up for Sanofi: Sanofi Delivers Business EPS Growth of 10.3% at CER investment picks
Glancy Binkow & Goldberg LLP reminds investors of Sanofi (the “Company”) (NYSE:SNY) that purchasers of Sanofi securities between February 7, 2013 and December 3, 2014, inclusive (the “Class Period”), have until February 2, 2015, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Southern District of New York.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Sanofi investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Sanofi Companies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Sandridge Energy  |  Next: Savanna Energy Services